Latest news
Tyra Biosciences 2Q 2026: Net loss $45.6M, EPS $(0.69) — 10-Q Summary - TradingViewTradingView · Tue, 04 Aug 2026 20:51:02 GMTTYRA: Q2 net loss rose to $45.6M as R&D spending increased; cash runway extends into 2028 - TradingViewTradingView · Tue, 04 Aug 2026 20:43:28 GMTTyra Biosciences Q2 net loss widens on higher R&D expenses - TradingViewTradingView · Tue, 04 Aug 2026 20:32:28 GMTTyra Biosciences posts Q2 2026 net loss $45.6M; cash $353.9M, runway into 2H 2028 - TradingViewTradingView · Tue, 04 Aug 2026 20:13:01 GMTTYRA: Phase 2 trials progress, strong cash runway, and higher R&D drive increased net loss - TradingViewTradingView · Tue, 04 Aug 2026 20:08:55 GMTTyra Biosciences Reports Second Quarter 2026 Financial Results and Recent Highlights - TradingViewTradingView · Tue, 04 Aug 2026 20:05:00 GMTTYRA Q2'26 Earnings: revenue estimate is 0 USD - TradingViewTradingView · Thu, 30 Jul 2026 07:00:00 GMT